132 related articles for article (PubMed ID: 20680693)
1. Prognostic significance of the alterations of the G1-S checkpoint in localized leiomyosarcoma of the peripheral soft tissue.
Panelos J; Beltrami G; Scoccianti G; Capanna R; Paglierani M; Pepi M; Massi D; Franchi A
Ann Surg Oncol; 2011 Feb; 18(2):566-71. PubMed ID: 20680693
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
3. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Jang JJ
Hum Pathol; 2002 Sep; 33(9):877-83. PubMed ID: 12378511
[TBL] [Abstract][Full Text] [Related]
4. Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.
Lusby K; Savannah KB; Demicco EG; Zhang Y; Ghadimi MP; Young ED; Colombo C; Lam R; Dogan TE; Hornick JL; Lazar AJ; Hunt KK; Anderson ML; Creighton CJ; Lev D; Pollock RE
Ann Surg Oncol; 2013 Jul; 20(7):2364-72. PubMed ID: 23334251
[TBL] [Abstract][Full Text] [Related]
5. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
[TBL] [Abstract][Full Text] [Related]
6. Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.
Lee K; Jung ES; Choi YJ; Lee KY; Lee A
J Korean Med Sci; 2010 Oct; 25(10):1449-55. PubMed ID: 20890425
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
Creager AJ; Cohen JA; Geradts J
Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of G1 regulatory proteins in human soft tissue sarcomas.
Yoo J; Park SY; Kang SJ; Shim SI; Kim BK
Arch Pathol Lab Med; 2002 May; 126(5):567-73. PubMed ID: 11958662
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.
Gavressea T; Kalogeras KT; Koliou GA; Zagouri F; Lazaridis G; Gogas H; Tsigaridas K; Koutras A; Petraki K; Markopoulos C; Pazarli E; Aravantinos G; Papadimitriou C; Papakostas P; Koufopoulos N; Karanikiotis C; Chrisafi S; Kalofonos HP; Pectasides D; Fountzilas G; Pavlakis K
Anticancer Res; 2017 Jun; 37(6):2947-2957. PubMed ID: 28551632
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma.
Jayasurya R; Sathyan KM; Lakshminarayanan K; Abraham T; Nalinakumari KR; Abraham EK; Nair MK; Kannan S
Mod Pathol; 2005 Aug; 18(8):1056-66. PubMed ID: 15731778
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
12. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
Saitoh G; Sugio K; Ishida T; Sugimachi K
Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
[TBL] [Abstract][Full Text] [Related]
14. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
[TBL] [Abstract][Full Text] [Related]
15. [Alterations of cell cycle regulating proteins: Rb, p21 and p16 in laryngeal cancer].
Pietruszewska W; Durko M; Kobos J
Otolaryngol Pol; 2007; 61(6):951-7. PubMed ID: 18546941
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
17. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
[TBL] [Abstract][Full Text] [Related]
20. Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
Naka T; Boltze C; Kuester D; Schulz TO; Schneider-Stock R; Kellner A; Samii A; Herold C; Ostertag H; Roessner A
Cancer; 2005 Sep; 104(6):1255-63. PubMed ID: 16078265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]